Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chester A Mathis

Showing results (161-170 of 203) with videos related to

Pageof 21
Sort By:
Brain Sciences|September 28, 2021
Comparing Pathological Risk Factors for Dementia between Cognitively Normal Japanese and AmericansChendi Cui, Aya Higashiyama, Brian J Lopresti, et al.
Journal of Alzheimer'S Disease : JAD|August 9, 2024
Implementation and Assessment of Tau Thresholds in Non-Demented Individuals as Predictors of Cognitive Decline in Tau Imaging StudiesAlexandra Gogola, Ann D Cohen, Beth Snitz, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2020
Amyloid accumulation in Down syndrome measured with amyloid loadMatthew D Zammit, Charles M Laymon, Tobey J Betthauser, et al.
Annals of Neurology|February 1, 2011
Longitudinal assessment of Aβ and cognition in aging and Alzheimer diseaseVictor L Villemagne, Kerryn E Pike, Gaël Chételat, et al.
Annals of Neurology|April 19, 2013
In vivo assessment of amyloid-β deposition in nondemented very elderly subjectsChester A Mathis, Lewis H Kuller, William E Klunk, et al.
Brain : a Journal of Neurology|March 15, 2008
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's diseaseMilos D Ikonomovic, William E Klunk, Eric E Abrahamson, et al.
Annals of Neurology|August 9, 2007
Imaging of amyloid burden and distribution in cerebral amyloid angiopathyKeith A Johnson, Matt Gregas, John A Becker, et al.
The Lancet. Neurology|March 2, 2010
11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose studyJuha O Rinne, David J Brooks, Martin N Rossor, et al.
Neuroimage. Clinical|June 28, 2021
Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndromeMatthew D Zammit, Dana L Tudorascu, Charles M Laymon, et al.
Molecular Psychiatry|October 27, 2018
Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imagingQi Yan, Kwangsik Nho, Jorge L Del-Aguila, et al.
Pageof 21

Showing results (161-170 of 203) with videos related to

Sort By:
Pageof 21
Brain Sciences|September 28, 2021
Comparing Pathological Risk Factors for Dementia between Cognitively Normal Japanese and AmericansChendi Cui, Aya Higashiyama, Brian J Lopresti, et al.
Journal of Alzheimer'S Disease : JAD|August 9, 2024
Implementation and Assessment of Tau Thresholds in Non-Demented Individuals as Predictors of Cognitive Decline in Tau Imaging StudiesAlexandra Gogola, Ann D Cohen, Beth Snitz, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2020
Amyloid accumulation in Down syndrome measured with amyloid loadMatthew D Zammit, Charles M Laymon, Tobey J Betthauser, et al.
Annals of Neurology|February 1, 2011
Longitudinal assessment of Aβ and cognition in aging and Alzheimer diseaseVictor L Villemagne, Kerryn E Pike, Gaël Chételat, et al.
Annals of Neurology|April 19, 2013
In vivo assessment of amyloid-β deposition in nondemented very elderly subjectsChester A Mathis, Lewis H Kuller, William E Klunk, et al.
Brain : a Journal of Neurology|March 15, 2008
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's diseaseMilos D Ikonomovic, William E Klunk, Eric E Abrahamson, et al.
Annals of Neurology|August 9, 2007
Imaging of amyloid burden and distribution in cerebral amyloid angiopathyKeith A Johnson, Matt Gregas, John A Becker, et al.
The Lancet. Neurology|March 2, 2010
11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose studyJuha O Rinne, David J Brooks, Martin N Rossor, et al.
Neuroimage. Clinical|June 28, 2021
Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndromeMatthew D Zammit, Dana L Tudorascu, Charles M Laymon, et al.
Molecular Psychiatry|October 27, 2018
Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imagingQi Yan, Kwangsik Nho, Jorge L Del-Aguila, et al.
Pageof 21